Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.31 +0.01 (+4.40%)
As of: Sep 10, 2026 · 10:36 AM EDT

Senti Biosciences Holdings (SNTI) Net Margin (QoQ) (2021 - 2023)

Analysis

Senti Biosciences Holdings (SNTI) Net Margin (QoQ) (2021 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.25 Bn 9.40 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.06 Bn 5.06 Bn -
3 Iovance Biotherapeutics 3.74 Bn 3.45 Bn 55.72 Mn
4 Legend Biotech 3.58 Bn 2.62 Bn 251.50 Mn
5 uniQure 3.01 Bn 3.01 Bn 5.49 Mn
6 Beam Therapeutics 2.54 Bn 2.54 Bn -
7 Precigen 2.37 Bn 2.37 Bn 52.17 Mn
8 Sarepta Therapeutics 2.21 Bn 1.42 Bn 251.87 Mn
9 Vericel 1.95 Bn 1.79 Bn 56.40 Mn
10 Senti Biosciences Holdings 9.61 Mn 9.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -438,005.00
Jun 30, 2023 -55,098.00
Mar 31, 2023 3.96 Mn
Dec 31, 2022 -4.01 Mn
Sep 30, 2022 66,443.00
Jun 30, 2022 -53,650.00
Mar 31, 2022 -57,828.00
Dec 31, 2021 54,878.00
Sep 30, 2021 9,900.00